Who are we?
Isotopia Molecular Imaging Ltd. is a collaboration between The Metrontario Group and some of Israel’s leading scientists in the field of radiopharmaceuticals.
Actively involved in Isotopia are highly experienced and renowned experts in the area of Nuclear Medicine and Molecular Imaging. The team includes Radiopharmacists, Nuclear Engineers, Chemists, Technicians and logistics experts.
In our state of the art facility we produce short lived PET and SPECT radiopharmaceuticals . We implement the highest level of isotope production methods, radiochemical synthesis, purification, and quality control. Isotopia uses our own logistics teams, certified by the competent authorities for preparing the doses in the safest and most practical method for delivery to your facility.
Our radiopharmaceutical production quality assurance system ensures that we deliver a quality dose, in compliance with the requirements of the health authorities, coupled with safety measures and on-time delivery.
We are interested in collaboration with the medical & scientific community to further develop and trial new markers in molecular imaging.
Drugs Disributed by Isotopia Molecular Imaging, Israel
Diagnostic Radiopharmaceuticals. Tetrakis 1 mg. VIAL (multidose): 5 × 15 ml.
Adult pts. ≈ (70 kg): Myocar.
scintigraphy: 400-900 MBq. Assessment
of global ventr. func.: 600-800 MBq inj.
as a bolus. Other: See lit.
Myocar. perf. scintigraphy: Detec., local. of
coron. artery dis., MI. Assessment of global
ventr. func.:1st - pass technique for determ.
of eject. fraction and/or ECG-triggered,
gated SPECT for eval. of left vent. ejection
fraction, volumes and regional wall
motion. Scinti-mammography for the
detec.of susp.breast cancer: Detect. of susp. breast cancer when mammography is
equivocal, inadequate or indeterminate.
Local. of hyperfunct. parathyroid tissue: in
pts. with recurrent or persistent
hyperparathyroidism, and in pts. scheduled
to undergo surgery of the parathyroid
glands.
C/I: Hypersens.
Yttrium (90-Y) Compound. Yttrium Chloride 1850 MBQ. VIAL (sol. for inject.): 1 x 2 ml. See lit.
Radiolabel. carrier molecules specific.
develop./authorized with radionuclei
(Zevalin).
C/I: Not to admin. direct. to pt.,
hypersens., pregn.
